Every complaint requires more than documentation; it requires experienced regulatory judgment. Elexes helps medical device manufacturers make timely reportability decisions, strengthen complaint investigations, and ensure complaint findings drive the right regulatory and quality actions.
Most manufacturers can log complaints. The real challenge is making the right decisions after a complaint is received.
Your team needs to determine:
⦿ Is the complaint reportable?
⦿ Does the investigation go deep enough?
⦿ Should it trigger CAPA?
⦿ Does the Risk Management File need updating?
⦿ Should supplier quality or engineering be involved?
⦿ Have regulatory reporting timelines started?
⦿ Is the complaint file inspection-ready?
When these decisions are inconsistent, organizations face delayed reporting, repeated product issues, ineffective CAPA, and regulatory observations.
Our Medical Device Complaint & Vigilance Review service provides an independent review of complaint records to help you report medical device events correctly, strengthen investigations, improve complaint governance, and connect complaints with broader quality and regulatory processes.
Complaint review and vigilance review are closely connected. A complaint may appear routine at intake, but further review may reveal that it requires regulatory reporting, additional investigation, PMS evaluation, CAPA escalation, or documentation of a rationale for reportability.
Elexes reviews complaint information to support decisions around:
⦿ Serious incident/MDR reportability
⦿ Jurisdiction-specific reporting timelines
⦿ Need for additional information before reportability decisions
⦿ Complaint-to-vigilance escalation
⦿ PMS and trend implications
⦿ Documentation of reportability rationale
This helps manufacturers avoid treating vigilance as a separate activity that happens after complaint closure. Instead, reportability and vigilance considerations are built into the complaint review process before final decisions are made.
After reportability and vigilance considerations are identified, each complaint should undergo a structured review process before closure. Elexes applies expert regulatory and quality judgment at each stage to support consistent, well-documented complaint decisions.
Assessment of the reportability of the complaint based on regulatory requirements and evidence.
Examine how the complaint was investigated, whether the root cause is supported, and whether the records justify complaint closure.
Identify if the complaint calls for any further action, such as CAPA, risk updates, or support from other teams.
Review how the complaint was handled and whether the records are complete and ready for inspection.
Struggling for an efficient approach to review complaint files in a consistent manner?
Get our free checklist to guide your team through reportability assessment, verify investigation completeness, and identify potential actions related to CAPA, risk management, supplier quality, and engineering before closing a complaint.
Proper complaint management depends on timely and well-informed decisions. Complaint Review improves your business's complaint management process by ensuring consistency, compliance, and cross-departmental decision-making.
A structured method can be used to make decisions regarding the need to report complaints.
Enhance the quality of your complaint investigation process through better evidence, root cause analysis, and complaint closure documentation.
Support compliance with FDA, EU MDR, Health Canada, and TGA complaint handling and vigilance requirements.
Link the results of your complaint handling with CAPA, risk management, supplier quality, engineering, maintenance, post-market surveillance, etc.
Maintain well-documented complaint files that demonstrate consistent evaluations and support regulatory inspections.
Identify reportable events early to minimize the risk of delayed reporting and regulatory observations.
Identify recurring complaint patterns that may require product improvements, corrective actions, or process changes.
Handling complaints is not only about following a process. It requires regulatory judgement, technical expertise, and a clear understanding of how complaint decisions affect the wider quality system.
We understand complaint reporting expectations across FDA, EU MDR, Health Canada, and TGA, helping manufacturers make consistent and well-supported reportability decisions.
We assess whether complaints should trigger actions across CAPA, Risk Management, Supplier Quality Engineering, Product Development Maintenance, Post-Market Surveillance. This helps ensure complaint data drives meaningful quality and product improvements.
Our reviews support reportability assessment by evaluating whether complaints may require regulatory reporting, further investigation, CAPA, risk management updates, or supplier quality review.
Our focus is on improving Complaint consistency, Investigation adequacy Documentation quality, Complaint closure evidence, Regulatory defensibility
The expectation for complaint reporting continues to change and develop in different jurisdictions. We monitor regulatory changes relevant to our review process and incorporate them.
Support can be customized based on your needs:
⦿ Monthly complaint reviews
⦿ Selected complaint assessments
⦿ Historical complaint backlog remediation
⦿ Ongoing governance support
⦿ Audit preparation
⦿ Independent expert reviews
Based on the type of engagement, you will get the following:
⦿ Complaint Review Report: Summary of findings and recommendations
⦿ Reportability Assessment Summary: Reportability decisions with supporting rationale
⦿ Investigation Adequacy Review: Assessment of investigation quality and evidence
⦿ Complaint Trend Summary: Analysis of recurring complaint patterns
⦿ Complaint Governance Report: Review of complaint management practices
⦿ CAPA Recommendation Summary: Recommended corrective and preventive actions
⦿ Risk Management Impact Recommendations: Potential updates to the Risk Management File
⦿ Regulatory Reporting Recommendations: Guidance on reportability and reporting obligations
This service is designed for organizations looking to strengthen their complaint handling and post-market processes, including:
⦿ Medical Device Manufacturers
⦿ IVD Manufacturers
⦿ SaMD Companies
⦿ Quality Managers
⦿ Regulatory Affairs Teams
⦿ Complaint Handling Teams
⦿ Post-Market Surveillance Teams
It is ideal for organisations managing increasing complaint volumes, preparing for inspections, or seeking an independent review of complaint decisions.
This service does not include:
⦿ Complaint intake outsourcing
⦿ Call center support
⦿ Product servicing
⦿ Legal representation
⦿ Regulatory authority submission execution
⦿ Replacement of your internal Quality Management System (QMS) or complaint handling process
Instead, we provide independent reviews and practical recommendations to help strengthen your existing complaint management system.
Whether a complaint requires regulatory reporting, CAPA, Risk Management updates, supplier action, or product improvement, experienced regulatory judgment is essential.
We assess the event details, patient impact, device performance, investigation findings, and the regulatory requirement for determining the reportability of the complaint.
Yes. We review complaints against the reporting requirements of FDA, EU MDR, Health Canada, and TGA to support consistent reportability decisions and strengthen regulatory compliance.
Yes. We can review selected high-risk complaints, historical complaint files, or complaint backlogs without assessing your entire complaint handling process.
Depending on the scope, deliverables may include a Complaint Review Report, Reportability Assessment Summary, Investigation Adequacy Review, Complaint Trend Summary, Complaint Governance Report, and recommendations for CAPA, risk management, and regulatory reporting.
Yes. We work collaboratively with your Quality and Regulatory teams, providing independent reviews and recommendations while your organization retains ownership of complaint handling and regulatory decisions.
Our process begins with an in-depth consultation where we learn about your medical device, its intended use, and your specific goals. This helps us tailor our assessment to your unique needs.
Our team of experts is well-versed in global medical device regulations, including FDA submissions, CE marking, TGA requirement, Health Canada approvals, ISO, and more. We stay up-to-date with the latest changes in the regulatory landscape.
We will conduct a comprehensive review of your existing documentation, including design files, clinical data, quality management systems, and risk assessments.
Our consultants will perform a gap analysis to identify any areas where your device may fall short of compliance. This forms the basis for our recommendations.
Based on our findings, we will provide you with detailed recommendations and a roadmap for achieving compliance. This may involve revising documentation, conducting additional testing, or making necessary design changes.
Our services don't stop with just the assessment. We offer ongoing support to guide you through the compliance process, helping you address any challenges that may arise.
Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.
Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.
Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.
At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.
We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.
We offer different services that will help you not only keep your product well in boundaries of regulations but also speed up the entire approval process. Some of these services are -
CEO Masterlink, Arizona
CEO Novasignal, Los Angeles
President ViDava, Florida
Sr. Exe Treedental, Hong Kong
Manager Outset Medical, California
CTO Jana Care, Massachusetts
MD Blackrock Pharma, England
VP Regulatory AliveCor, California
Owner Liz Inc., Arizona
CEO Radformation, New York
Never miss out on any important update on the regulatory & compliance industry across the globe. Subscribe to our newsletter now.
Copyright 2025, Elexes Medical Consulting Pvt. Ltd. All Rights Reserved
Working Hours : Monday to Friday 9:00 AM - 7:00 PM
Team Elexes 
